Bromodomain and extraterminal (BET) protein inhibition of IgG/IgE production in murine B cells is counter‐balanced by a strong Th2 bias

OBJECTIVES: Inhibitors of bromodomain and extra terminal domain (BET) proteins are a new and growing class of anti‐cancer drugs, which decrease oncogene expression by targeting superenhancers. Antibody production is another physiological process relying on superenhancers, and it remains to be clarif...

Ful tanımlama

Kaydedildi:
Detaylı Bibliyografya
Yayımlandı:Clin Transl Immunology
Asıl Yazarlar: Dalloul, Zeinab, Best, Marie, Chenuet, Pauline, Dalloul, Iman, Le Noir, Sandrine, Togbé, Dieudonnée, Gador, Mylène, Ryffel, Bernhard, FJ Quesniaux, Valerie, El Makhour, Yolla, Boyer, François, Aldigier, Jean‐Claude, Cook‐Moreau, Jeanne, Fazilleau, Nicolas, Cogné, Michel
Materyal Türü: Artigo
Dil:Inglês
Baskı/Yayın Bilgisi: John Wiley and Sons Inc. 2021
Konular:
Original Article
Online Erişim:https://ncbi.nlm.nih.gov/pmc/articles/PMC8164936/
https://ncbi.nlm.nih.gov/pubmed/34136216
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1002/cti2.1280
Etiketler: Etiketle
Etiket eklenmemiş, İlk siz ekleyin!

Benzer Materyaller